State Street Corporation 13D and 13G filings for Zentalis Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-18 12:50 pm Sale | 2024-09-30 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | STATE STREET CORP STT | 1,246,613 1.800% | -3,170,443 (-71.78%) | Filing |
| 2024-01-25 07:52 am Purchase | 2023-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | STATE STREET CORP STT | 4,417,056 6.240% | 1,332,919 (+43.22%) | Filing |
| 2023-02-07 1:20 pm Purchase | 2022-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | STATE STREET CORP STT | 3,084,137 5.400% | 3,084,137 (New Position) | Filing |